Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates

Human Immunology

Volumn 76, Issue 1, 2015, Pages 65-73

  Rueda, Cesar M ^a   Wells, Casey B ^a   Gisslen, Tate ^b   Jobe, Alan H ^b   Kallapur, Suhas G ^b   Chougnet, Claire A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Fetal inflammation; Full term newborn; Prematurity; Regulatory T cell; Suppression

Indexed keywords

ANTIBIOTIC AGENT; CD39 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; KI 67 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID; APYRASE; CD45 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; TIGIT PROTEIN, HUMAN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CELL ACTIVITY; CELL CYCLE; CELL ISOLATION; CELL SELECTION; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FUNISITIS; HOSPITALIZATION; HUMAN; HUMAN CELL; HYPERTENSION; IN VITRO STUDY; INFLAMMATORY CELL; MALE; MEDICAL RECORD REVIEW; MONONUCLEAR CELL; NEWBORN; PHENOTYPE; PLACENTAL DELIVERY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STEROID THERAPY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; UMBILICAL CORD BLOOD; UMBILICAL VEIN; CELL SEPARATION; CYTOLOGY; FETUS BLOOD; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOLOGY; PREGNANCY; PRIMARY CELL CULTURE; SEVERITY OF ILLNESS INDEX;

ADULT; ANTIGENS, CD; ANTIGENS, CD45; APYRASE; CELL SEPARATION; CHORIOAMNIONITIS; FEMALE; FETAL BLOOD; GENE EXPRESSION; HLA-DR ANTIGENS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; KI-67 ANTIGEN; LYMPHOCYTE ACTIVATION; PHENOTYPE; PREGNANCY; PRIMARY CELL CULTURE; RECEPTORS, IMMUNOLOGIC; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

EID: 84920749733     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.10.016     Document Type: Article

References (54)

1. Ananth C.V., Friedman A.M., Gyamfi-Bannerman C. Epidemiology of moderate preterm, late preterm and early term delivery. Clin perinatol 2013, 40:601-610.
2. Martin J.A., Osterman M.J., Sutton P.D. Are preterm births on the decline in the United States? Recent data from the National Vital Statistics System. NCHS Data Brief 2010, 1-8.
3. McIntire D.D., Leveno K.J. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol 2008, 111:35-41.
4. Goyal N.K., Fiks A.G., Lorch S.A. Association of late-preterm birth with asthma in young children: practice-based study. Pediatrics 2011, 128:e830-e838.
5. Vrijlandt E.J., Kerstjens J.M., Duiverman E.J., Bos A.F., Reijneveld S.A. Moderately preterm children have more respiratory problems during their first 5years of life than children born full term. Am J Respir Crit Care Med 2013, 187:1234-1240.
6. Erdemir G., Kultursay N., Calkavur S., Zekioglu O., Koroglu O.A., Cakmak B., et al. Histological chorioamnionitis: effects on premature delivery and neonatal prognosis. Pediatr Neonatol 2013, 54:267-274.
7. Getahun D., Strickland D., Zeiger R.S., Fassett M.J., Chen W., Rhoads G.G., et al. Effect of chorioamnionitis on early childhood asthma. Arch Pediatr Adolesc Med 2010, 164:187-192.
8. Lee S.M., Park J.W., Kim B.J., Park C.W., Park J.S., Jun J.K., et al. Acute histologic chorioamnionitis is a risk factor for adverse neonatal outcome in late preterm birth after preterm premature rupture of membranes. PloS One 2013, 8:e79941.
9. Luciano A.A., Yu H., Jackson L.W., Wolfe L.A., Bernstein H.B. Preterm labor and chorioamnionitis are associated with neonatal T cell activation. PloS One 2011, 6:e16698.
10. Crespo M., Martinez D.G., Cerissi A., Rivera-Reyes B., Bernstein H.B., Lederman M.M., et al. Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurity. Pediatr Res 2012, 71:136-143.
11. Kallapur S.G., Kramer B.W., Nitsos I., Pillow J.J., Collins J.J., Polglase G.R., et al. Pulmonary and systemic inflammatory responses to intra-amniotic IL-1alpha in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011, 301:L285-L295.
12. Gisslen T., Hillman N.H., Musk G.C., Kemp M.W., Kramer B.W., Senthamaraikannan P., et al. Repeated exposure to intra-amniotic LPS partially protects against adverse effects of intravenous LPS in preterm lambs. Innate Immun 2013.
13. Wolfs T.G., Kallapur S.G., Polglase G.R., Pillow J.J., Nitsos I., Newnham J.P., et al. IL-1alpha mediated chorioamnionitis induces depletion of FoxP3+ cells and ileal inflammation in the ovine fetal gut. PloS One 2011, 6:e18355.
14. Wing K., Sakaguchi S. Regulatory T, cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010, 11:7-13.
15. Lal G., Bromberg J.S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009, 114:3727-3735.
16. Runyon R.S., Cachola L.M., Rajeshuni N., Hunter T., Garcia M., Ahn R., et al. Asthma discordance in twins is linked to epigenetic modifications of T cells. PloS One 2012, 7:e48796.
17. Redline R.W., Faye-Petersen O., Heller D., Qureshi F., Savell V., Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003, 6:435-448.
18. Presicce P., Moreno-Fernandez M.E., Lages C.S., Orsborn K.I., Chougnet C.A. Association of two clones allows for optimal detection of human FOXP3. Cytometry A 2010, 77:571-579.
19. Sattui S., de la Flor C., Sanchez C., Lewis D., Lopez G., Rizo-Patron E., et al. Cryopreservation modulates the detection of regulatory T cell markers. Cytometry B Clin Cytom 2012, 82:54-58.
20. Golab K., Leveson-Gower D., Wang X.J., Grzanka J., Marek-Trzonkowska N., Krzystyniak A., et al. Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications. Int Immunopharmacol 2013, 16:371-375.
21. Mavin E., Dickinson A., Wang X.N. Do cryopreserved regulatory T cells retain their suppressive potency?. Transplantation 2013, 95:e68-e70.
22. Ryden A., Faresjo M. Efficient expansion of cryopreserved CD4(+)CD25(+)CD127(lo/-) cells in type 1 diabetes. Results Immunol 2011, 1:36-44.
23. Venet F., Malcus C., Ferry T., Poitevin F., Monneret G. Percentage of regulatory T cells CD4+CD25+CD127- in HIV-infected patients is not reduced after cryopreservation. J Immunol Methods 2010, 357:55-58.
24. Van Hemelen D., Oude Elberink J.N., Heimweg J., van Oosterhout A.J., Nawijn M.C. Cryopreservation does not alter the frequency of regulatory T cells in peripheral blood mononuclear cells. J Immunological Methods 2010, 353:138-140.
25. Nettenstrom L., Alderson K., Raschke E.E., Evans M.D., Sondel P.M., Olek S., et al. An optimized multi-parameter flow cytometry protocol for human T regulatory cell analysis on fresh and viably frozen cells, correlation with epigenetic analysis, and comparison of cord and adult blood. J Immunological Methods 2013, 387:81-88.
26. Presicce P., Orsborn K., King E., Pratt J., Fichtenbaum C.J., Chougnet C.A. Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. PloS One 2011, 6:e28118.
27. Belkaid Y. Regulatory T, cells and infection: a dangerous necessity. Nat Rev Immunol 2007, 7:875-888.
28. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998, 179:194-202.
29. Rogers B.B., Alexander J.M., Head J., McIntire D., Leveno K.J. Umbilical vein interleukin-6 levels correlate with the severity of placental inflammation and gestational age. Hum Pathol 2002, 33:335-340.
30. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203:1693-1700.
31. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006, 203:1701-1711.
32. Michaelsson J., Mold J.E., McCune J.M., Nixon D.F. Regulation of T cell responses in the developing human fetus. J Immunol 2006, 176:5741-5748.
33. Dirix V., Vermeulen F., Mascart F. Maturation of CD4(+) regulatory T lymphocytes and of cytokine secretions in infants born prematurely. J Clin Immunol 2013, 33:1126-1133.
34. Takahata Y., Nomura A., Takada H., Ohga S., Furuno K., Hikino S., et al. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp Hematol 2004, 32:622-629.
35. Mold J.E., Michaelsson J., Burt T.D., Muench M.O., Beckerman K.P., Busch M.P., et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008, 322:1562-1565.
36. Burt T.D. Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease. Am J Reprod Immunol 2013, 69:346-358.
37. Correa-Rocha R., Perez A., Lorente R., Ferrando-Martinez S., Leal M., Gurbindo D., et al. Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7. Pediatr Res 2012, 71:590-597.
38. Kunzmann S., Glogger K., Been J.V., Kallapur S.G., Nitsos I., Moss T.J., et al. Thymic changes after chorioamnionitis induced by intraamniotic lipopolysaccharide in fetal sheep. Am J Obstet Gynecol 2010, 202(476):e1-e9.
39. Kuypers E., Wolfs T.G., Collins J.J., Jellema R.K., Newnham J.P., Kemp M.W., et al. Intraamniotic lipopolysaccharide exposure changes cell populations and structure of the ovine fetal thymus. Reprod Sci 2013.
40. Kallapur S.G., Presicce P., Senthamaraikannan P., Alvarez M., Tarantal A.F., Miller L.M., et al. Intra-Amniotic IL-1beta Induces Fetal Inflammation in Rhesus Monkeys and Alters the Regulatory T Cell/IL-17 Balance. J Immunol 2013, 191:1102-1109.
41. Ng W.F., Duggan P.J., Ponchel F., Matarese G., Lombardi G., Edwards A.D., et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001, 98:2736-2744.
42. Grindebacke H., Stenstad H., Quiding-Jarbrink M., Waldenstrom J., Adlerberth I., Wold A.E., et al. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. J Immunol 2009, 183:4360-4370.
43. Schlossberger V., Schober L., Rehnitz J., Schaier M., Zeier M., Meuer S., et al. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets. Hum Reprod 2013.
44. Bulgarini D., Scalzo S., Boccoli G., Petrini M., Quaranta M.T., Camagna A., et al. IL-6/BSF-2 selectively stimulates the GO--S progression of CD8+ lymphocytes. J Biol Regul Homeost Agents 1991, 5:23-33.
45. Hong C., Nam A.S., Keller H.R., Ligons D.L., Park J.Y., Yoon H.W., et al. Interleukin-6 expands homeostatic space for peripheral T cells. Cytokine 2013, 64:532-540.
46. Wing K., Larsson P., Sandstrom K., Lundin S.B., Suri-Payer E., Rudin A. CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses. Immunology 2005, 115:516-525.
47. Mayer E., Bannert C., Gruber S., Klunker S., Spittler A., Akdis C.A., et al. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter. PloS One 2012, 7:e29355.
48. Fan H., Yang J., Hao J., Ren Y., Chen L., Li G., et al. Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood. Immunology 2012, 136:218-230.
49. Lee C.C., Lin S.J., Cheng P.J., Kuo M.L. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15. Pediatr Allergy Immunol 2009, 20:624-632.
50. Steinborn A., Engst M., Haensch G.M., Mahnke K., Schmitt E., Meuer S., et al. Small for gestational age (SGA) neonates show reduced suppressive activity of their regulatory T cells. Clin Immunol 2010, 134:188-197.
51. Oberg H.H., Ly T.T., Ussat S., Meyer T., Kabelitz D., Wesch D. Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands. J Immunol 2010, 184:4733-4740.
52. Lal G., Yin N., Xu J., Lin M., Schroppel S., Ding Y., et al. Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function. Am J Transplant 2011, 11:203-214.
53. Nyirenda M.H., Sanvito L., Darlington P.J., O'Brien K., Zhang G.X., Constantinescu C.S., et al. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J Immunol 2011, 187:2278-2290.
54. Luciano AA, Arbona-Ramirez IM, Ruiz R, Llorens-Bonilla BJ, Martinez-Lopez DG, Funderburg N, et al. Alterations in regulatory T cell subpopulations seen in preterm infants. PloS one. 2014;9:e95867.